Blog
PRIMR Work Culture: Core Values
By: David Grew MD MPH
"Welcoming new hires who resonate with these values ensures our collective dedication to making a meaningful impact in the industry."
∗ ∗ ∗
As our startup expands this year, we will share our core values with every team member. With a focus on patient centricity, a preference for simplicity, and "Fail fast, iterate" mentality, our culture emphasizes a commitment to improving healthcare experiences, streamlined processes, and an innovative, adaptive mindset. Welcoming new hires who resonate with these values ensures our collective dedication to making a meaningful impact in the industry.
Here are PRIMR’s core values and why they drive our business forward:
We work for the patient.
- Our accumulated experience and knowledge are based on feedback from real patients with real problems sharing a
- their lived experiences.
- Patients teach which parts of medical treatments are hard to understand.
- Patients teach us which explanations and visuals make complex medical concepts and treatments easier to understand.
- The knowledge we gain from patients compounds over time and we harness this to improve our products.
- We exist to transform the intimacy and magic of a curated doctor-patient explanation into a scalable asset.
Simplicity is king.
- When an explanation is complex the explainer doesn’t fully understand the problem.
- We believe any patient can understand any medical problem and corresponding treatment.
- When complex problems are broken down into basic principles, the world of potential solutions is narrower and more intuitively obvious to the audience.
Fanatical attention to detail.
- Everything we create must be medically accurate.
- We must find a balance between simplicity and medical accuracy.
- Attention to detail means extreme precision, not excessive information.
- We need to thread the needle on keeping things simple and relatable for patients but medically precise to maintain trust and credibility with physician peers.
Make it look attractive.
- Even a sketch on a clinic exam table paper can be attractive.
- We use clean lines, black and white with primary colors to avoid distracting our audience from the core medical message.
- We avoid flashy graphics which can be a crutch against the inability to stand on your clear thinking.
We are scrappy.
- We come from grassroots, based on actual conversations between doctors and patients.
- We do not have venture capital backing, we are self-funded.
- We are a lean, nimble, global team with extreme talent diversity - this is an unfair advantage we enjoy.
- We are frugal in our spending and prioritize only the highest-leverage projects by the 80/20 principle.
- We aim to turn a profit to ensure our long-term financial viability and expand the number of patient lives we can impact.
Fail fast, iterate.
- We learn more from our failures than our successes.
- We are precise, and we do not callously or flippantly risk failure when it involves patients. But we recognize failures with clear eyes and rapidly iterate to change our process accordingly.
- The fastest way to optimize the impact of our content and its distribution is by taking calculated risks, and rapidly pivoting off failed strategies.
Accountability.
- Each team member is responsible for executing their role.
- When we make a mistake, we own it and explain what we did wrong, and how we’ll avoid it going forward.
- Accountability also means owning your wins. While we celebrate as a team, we call out specific team members whose efforts made an outsized impact on the outcome.
Compound by adding value.
- We harvest exponential growth by constantly seeking ways to add value to our customers. We ask, “How can we make this solve more of their problems?”
- We are patient with growth outcomes and reject a desperate “growth at all costs” philosophy. Instead, we believe the growth outcome takes care of itself when we “provide customer value at all costs.”
- We achieve non-linear growth by having repeat customers, in addition to steady new customer growth.
Other Posts
Breakthrough Treatment for Metastatic Cervical Cancer: The innovaTV 301 Trial
The innovaTV 301 trial evaluated the effectiveness of Tivdak, a novel drug, compared to standard chemotherapy in treating recurrent or metastatic cervical cancer. In this blog, we discuss how Tivdak significantly improved survival rates and reduced side effects, offering new hope for patients.
Read more
Understanding Circulating Tumor DNA (ctDNA) in Cancer Detection and Management
Learn how ctDNA is transforming cancer detection and monitoring. This blog delves into its advantages over traditional biopsies, its current uses, and future potential in personalized cancer care, offering a less invasive, more precise approach to managing your specific cancer.
Read more